Une chimiothérapie adjuvante par mitomycine, cisplatine et vindésine n’améliore pas la survie de cancers bronchiques non à petites cellules opérés
作者： M. Taulelle
DOI: 10.1016/S0761-8425(04)71956-7
关键词:
摘要:
sci-hub.se 参考文章(3)
Clifton F. Mountain, Revisions in the International System for Staging Lung Cancer Chest. ,vol. 111, pp. 1710- 1717 ,(1997) , 10.1378/CHEST.111.6.1710
Steven M. Keller, Sudeshna Adak, Henry Wagner, Arnold Herskovic, Ritsuko Komaki, Burke J. Brooks, Michael C. Perry, Robert B. Livingston, David H. Johnson, A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer The New England Journal of Medicine. ,vol. 343, pp. 1217- 1222 ,(2000) , 10.1056/NEJM200010263431703
T Le Chevalier, None, Results of the Randomized International Adjuvant Lung Cancer Trial (IALT): Cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC) Journal of Clinical Oncology. ,vol. 21, ,(2003)